GROUP ONE TRADING, L.P. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459958. A total of 3 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$2,454,000
+17.2%
72,500
+0.1%
0.01%
+66.7%
Q2 2022$2,094,000
+185.3%
72,400
+218.9%
0.00%
+200.0%
Q1 2022$734,000
+4.9%
22,700
-5.4%
0.00%0.0%
Q4 2021$700,000
+1455.6%
24,000
+1311.8%
0.00%
Q3 2021$45,000
-30.8%
1,700
-19.0%
0.00%
Q2 2021$65,000
-63.5%
2,100
-69.1%
0.00%
Q1 2021$178,000
+76.2%
6,800
+70.0%
0.00%
Q4 2020$101,000
+18.8%
4,000
-2.4%
0.00%
Q3 2020$85,000
-89.8%
4,100
-88.3%
0.00%
-100.0%
Q2 2020$831,000
-8.0%
35,000
-30.3%
0.00%
-42.9%
Q1 2020$903,000
-74.3%
50,200
-66.1%
0.01%
-70.8%
Q4 2019$3,518,000
-9.1%
148,300
+5.3%
0.02%
-22.6%
Q3 2019$3,872,000
+882.7%
140,900
+1084.0%
0.03%
+675.0%
Q2 2019$394,000
-49.8%
11,900
-46.9%
0.00%
-55.6%
Q1 2019$785,000
+27.0%
22,400
+20.4%
0.01%
+80.0%
Q4 2018$618,000
-31.0%
18,600
+4.5%
0.01%
-28.6%
Q3 2018$896,000
-28.7%
17,800
-15.2%
0.01%
-36.4%
Q2 2018$1,257,000
+134.5%
21,000
+79.5%
0.01%
+120.0%
Q1 2018$536,000
+169.3%
11,700
+134.0%
0.01%
+400.0%
Q4 2017$199,000
-82.8%
5,000
-82.7%
0.00%
-90.0%
Q3 2017$1,156,000
-48.2%
28,900
-44.2%
0.01%
-56.5%
Q2 2017$2,233,000
+76.5%
51,800
+28.2%
0.02%
+53.3%
Q1 2017$1,265,000
+78.9%
40,400
+44.3%
0.02%
+114.3%
Q4 2016$707,000
-27.6%
28,000
-29.1%
0.01%
-36.4%
Q3 2016$977,000
-13.1%
39,500
-28.4%
0.01%
-15.4%
Q2 2016$1,124,000
+87.6%
55,200
+40.5%
0.01%
+62.5%
Q1 2016$599,000
-31.2%
39,300
-39.4%
0.01%
-20.0%
Q4 2015$871,000
-21.2%
64,800
-17.8%
0.01%
-33.3%
Q3 2015$1,106,000
-6.8%
78,800
+12.7%
0.02%
-11.8%
Q2 2015$1,187,000
-17.3%
69,900
-41.1%
0.02%
-26.1%
Q1 2015$1,435,000
+546.4%
118,700
+342.9%
0.02%
+666.7%
Q4 2014$222,000
-19.0%
26,800
-14.9%
0.00%
-25.0%
Q3 2014$274,000
-80.9%
31,500
-75.9%
0.00%
-81.8%
Q2 2014$1,432,000
-53.2%
130,800
-61.8%
0.02%
-56.9%
Q1 2014$3,059,000
+235.0%
342,200
+182.6%
0.05%
+264.3%
Q4 2013$913,000
+125.4%
121,100
+119.0%
0.01%
+75.0%
Q3 2013$405,000
+76.1%
55,300
+54.5%
0.01%
+33.3%
Q2 2013$230,00035,8000.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 4,000$101,0000.00%
SIMPLEX TRADING, LLC 9$22,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders